Display Settings:

Format

Send to:

Choose Destination
    Allergy Asthma Proc. 2000 Mar-Apr;21(2):113-6.

    Venom immunotherapy: when to start, when to stop.

    Source

    Asthma and Allergic Diseases, Park Nicollet Clinic, Minneapolis, Minnesota 55416-2699, USA.

    Abstract

    Over the past 25 years, major advances have been made in the diagnosis and treatment of insect sting allergy. Controlled clinical trials have demonstrated the efficacy of venom immunotherapy (VIT) in the prevention of subsequent systemic reactions in allergic individuals. We have refined our criteria for selection of patients for VIT. Studies on selections of venoms, rush immunotherapy, and interval between VIT injections have been performed. Finally, much work has been done to try to define criteria for the discontinuation of VIT.

    PMID:
    10791113
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Ingenta plc

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk